A newly discovered biomarker can predict cancer aggressiveness
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...
Les Echos Patrimoine6h
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
Applied DNA Sciences exits DNA Tagging business segment. Workforce reduction and GMP site completion announced. Financial results for Q1 fiscal 2025 revealed ...
Le Lézard11h
Pfizer's TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...
Le Lézard11h
Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarketstm.
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...